570 Biowissenschaften; Biologie
Refine
Year of publication
- 2021 (376)
- 2020 (268)
- 2022 (250)
- 2017 (181)
- 2023 (168)
- 2018 (165)
- 2016 (157)
- 2019 (138)
- 2012 (137)
- 2010 (132)
- 2013 (130)
- 2009 (114)
- 2014 (111)
- 2015 (106)
- 2011 (100)
- 2008 (94)
- 2007 (73)
- 2006 (70)
- 2024 (64)
- 2005 (46)
- 2004 (38)
- 2003 (37)
- 2002 (22)
- 2001 (16)
- 1998 (14)
- 2000 (12)
- 1999 (9)
- 1981 (8)
- 1975 (7)
- 1990 (7)
- 1976 (6)
- 1977 (6)
- 1985 (6)
- 1971 (5)
- 1974 (5)
- 1984 (5)
- 1996 (5)
- 1980 (4)
- 1982 (3)
- 1989 (3)
- 1994 (3)
- 1995 (3)
- 1898 (2)
- 1901 (2)
- 1909 (2)
- 1920 (2)
- 1924 (2)
- 1957 (2)
- 1969 (2)
- 1970 (2)
- 1972 (2)
- 1979 (2)
- 1983 (2)
- 1986 (2)
- 1992 (2)
- 1993 (2)
- 1997 (2)
- 1597 (1)
- 1842 (1)
- 1843 (1)
- 1856 (1)
- 1859 (1)
- 1860 (1)
- 1875 (1)
- 1876 (1)
- 1881 (1)
- 1883 (1)
- 1897 (1)
- 1900 (1)
- 1903 (1)
- 1908 (1)
- 1910 (1)
- 1914 (1)
- 1918 (1)
- 1923 (1)
- 1927 (1)
- 1928 (1)
- 1933 (1)
- 1934 (1)
- 1937 (1)
- 1940 (1)
- 1945 (1)
- 1946 (1)
- 1959 (1)
- 1960 (1)
- 1961 (1)
- 1962 (1)
- 1963 (1)
- 1966 (1)
- 1967 (1)
- 1973 (1)
- 1978 (1)
- 1987 (1)
- 1991 (1)
Document Type
- Article (2093)
- Doctoral Thesis (737)
- Preprint (219)
- Part of Periodical (78)
- Book (16)
- Conference Proceeding (12)
- Part of a Book (10)
- Periodical (3)
- Report (2)
- Working Paper (2)
Language
- English (3174) (remove)
Is part of the Bibliography
- no (3174)
Keywords
- RNA (20)
- aging (20)
- SARS-CoV-2 (19)
- inflammation (18)
- taxonomy (17)
- Biochemistry (16)
- Podospora anserina (16)
- mitochondria (16)
- Cell biology (15)
- NMR (15)
Institute
- Biowissenschaften (1220)
- Biochemie und Chemie (550)
- Medizin (454)
- Biochemie, Chemie und Pharmazie (346)
- Institut für Ökologie, Evolution und Diversität (176)
- Senckenbergische Naturforschende Gesellschaft (160)
- Biodiversität und Klima Forschungszentrum (BiK-F) (123)
- Exzellenzcluster Makromolekulare Komplexe (116)
- MPI für Biophysik (104)
- Frankfurt Institute for Advanced Studies (FIAS) (94)
Argonaute 2 (AGO2) is an indispensable component of the RNA-induced silencing complex, operating at the translational or posttranscriptional level. It is compartmentalized into structures such as GW- and P-bodies, stress granules and adherens junctions as well as the midbody. Here we show using immunofluorescence, image and bioinformatic analysis and cytogenetics that AGO2 also resides in membrane protrusions such as open- and close-ended tubes. The latter are cytokinetic bridges where AGO2 colocalizes at the midbody arms with cytoskeletal components such as α-Τubulin and Aurora B, and various kinases. AGO2, phosphorylated on serine 387, is located together with Dicer at the midbody ring in a manner dependent on p38 MAPK activity. We further show that AGO2 is stress sensitive and important to ensure the proper chromosome segregation and cytokinetic fidelity. We suggest that AGO2 is part of a regulatory mechanism triggered by cytokinetic stress to generate the appropriate micro-environment for local transcript homeostasis.
Oncogenic transformation of lung epithelial cells is a multi-step process, frequently starting with the inactivation of tumor suppressors and subsequent activating mutations in proto-oncogenes, such as members of the PI3K or MAPK family. Cells undergoing transformation have to adjust to changes, such as metabolic requirements. This is achieved, in part, by modulating the protein abundance of transcription factors, which manifest these adjustments. Here, we report that the deubiquitylase USP28 enables oncogenic reprogramming by regulating the protein abundance of proto-oncogenes, such as c-JUN, c-MYC, NOTCH and ΔNP63, at early stages of malignant transformation. USP28 is increased in cancer compared to normal cells due to a feed-forward loop, driven by increased amounts of oncogenic transcription factors, such as c-MYC and c-JUN. Irrespective of oncogenic driver, interference with USP28 abundance or activity suppresses growth and survival of transformed lung cells. Furthermore, inhibition of USP28 via a small molecule inhibitor reset the proteome of transformed cells towards a ‘pre-malignant’ state, and its inhibition cooperated with clinically established compounds used to target EGFRL858R, BRAFV600E or PI3KH1047R driven tumor cells. Targeting USP28 protein abundance already at an early stage via inhibition of its activity therefore is a feasible strategy for the treatment of early stage lung tumours and the observed synergism with current standard of care inhibitors holds the potential for improved targeting of established tumors.
Neurodevelopmental psychiatric disorders (NPDs) like attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and schizophrenia, affect millions of people worldwide. Despite recent progress in NPD research, much remains to be discovered about their underpinnings, therapeutic targets, effects of biological sex and age. Risk factors influencing brain development and signalling include prenatal inflammation and genetic variation. This dissertation aimed to build upon these findings by combining behavioural, molecular, and neuromorphological investigations in mouse models of such risk factors, i.e. maternal immune activation (MIA), neuron-specific overexpression (OE) of the cytoplasmatic isoforms of the RNA-binding protein RBFOX1, and neuronal deletion of the small Ras GTPase DIRAS2.
Maternal infections during pregnancy pose an increased risk for NPDs in the offspring. While viral-like MIA has been previously established elsewhere, this study was the first in our institution to implement the model. I validated NPD-relevant deficits in anxiety- and depression-like behaviours, as well as dose- and sex-specific social deficits in mouse offspring following MIA in early gestation. Proteomic analyses in embryonic and adult hippocampal (HPC) synaptoneurosomes highlighted novel and known targets affected by MIA. Analysis of the embryonic dataset implicated neurodevelopmental disruptions of the lipid, polysaccharide, and glycoprotein metabolism, important for proper membrane function, signalling, and myelination, for NPD-pertinent sequelae. In adulthood, the observed changes encompassed transmembrane trafficking and intracellular signalling, apoptosis, and cytoskeletal organisation pathways. Importantly, 50 proteins altered by MIA in embryonic and adult HPC were enriched in the NPD-relevant synaptic vesicle cycle. A persistently upregulated protein cluster formed a functional network involved in presynaptic signalling and proteins downregulated in embryos but upregulated in adults by MIA were correlated with observed social deficits. 49/50 genes encoding these proteins were significantly associated with NPD- and comorbidity-relevant traits in human phenome-wise association study data for psychiatric phenotypes. These findings highlight NPD-relevant targets for future study and early intervention in at-risk individuals. MIA-evoked changes in the neuroarchitecture of the NPD-relevant HPC and prefrontal cortex (PFC) of male and female mice highlighted sex- and region-specific alterations in dendritic and spine morphology, possibly underlining behavioural phenotypes.
To further investigate genetic risk factors of NPDs, I performed a study based on the implications of RBFOX1’s pleiotropic role in neuropsychiatric disorders and previous preclinical findings. Cytoplasmatic OE of RBFOX1, which affects the stability and translation of thousands of targets, was used to disseminate its role in morphology and behaviour. RBFOX1 OE affected dendritic length and branching in the male PFC and led to spine alterations in both PFC and HPC. Due to previously observed ASD-like endophenotypes in our Rbfox1 KO mice and the importance of gene × environment effects on NPD susceptibility, I probed the interaction of cytoplasmatic OE and a low-dose MIA on offspring. Both RBFOX1 OE alone and with MIA led to increased offspring loss during the perinatal period. Preliminary data suggested that RBFOX1 OE × MIA might increase anxiety- and anhedonia-like behaviours. Morphological changes in the adult male OE HPC and PFC suggested increased spine density and reduced dendritic complexity. A small post-mortem study in human dorsolateral PFC of older adults did not reveal significant effects of a common risk variant on RBFOX1 abundance.
To expand upon NPD genetic risks, I evaluated the effects of a homo- (KO) or heterozygous (HET) Diras2 deletion in a novel, neuron-specific mouse model. DIRAS2’s function is largely unknown, but it has been associated with ADHD in humans and neurodevelopment in vitro. In adult mice, there were subtle sex-specific effects on behaviour, i.e. more pronounced NPD-relevant deficits in males, in keeping with human data. KO mice had subtly improved cognitive performance, while HET mice exhibited behaviours in line with core ADHD symptoms, e.g. earning difficulties (females), response inhibition deficits and hyperactivity (males), suggesting Diras2 dose-sensitivity and sex-specificity. The morphological findings revealed multiple aberrations in dendritic and spine morphology in the adult PFC, HPC, and amygdala of HET males. KOs changes in spine and dendritic morphology were exclusively in the PFC and largely opposite to those in HETs and NPD-like phenotypes. Region- and genotype-specific expression changes in Diras2 and Diras1 were observed in six relevant brain regions of adult HET and KO females, also revealing differences in the survival and morphology regulator mTOR, which might underlie observed differences.
In conclusion, the effects of MIA and partial Diras2 knockdown resembled each other in core, NPD-associated behavioural and morphological phenotypes, while cytoplasmatic RBFOX1 OE and full Diras2 KO differed from those. My findings suggest complex dose- and sex-dependent relationships between these prenatal and genetic interventions, whose NPD-relevant influences might converge onto neurodevelopmental molecular pathways. An assessment of such putative overlap, based on available data from the MIA proteomic analyses of embryonic and adult HPC, suggested the three models might be linked via downstream targets, interactions, and upstream regulators. Future studies should disseminate both distinct and shared aspects of MIA, RBFOX1, and DIRAS2 relevant to NPDs and build upon these findings.
Mitochondria are dynamic organelles exhibiting diverse shapes. While the variation of shapes, ranging from spheres to elongated tubules, and the transition between them, are clearly seen in many cell types, the molecular mechanisms governing this morphological variability remain poorly understood. Here, we propose a novel shaping mechanism based on the interplay between the inner and outer mitochondrial membranes. Our biophysical model suggests that the difference in surface area, arising from the pulling of the inner membrane into cristae, correlates with mitochondrial elongation. Analysis of live cell super-resolution microscopy data supports this correlation, linking elongated shapes to the extent of cristae in the inner membrane. Knocking down cristae shaping proteins further confirms the impact on mitochondrial shape, demonstrating that defects in cristae formation correlate with mitochondrial sphericity. Our results suggest that the dynamics of the inner mitochondrial membrane are important not only for simply creating surface area required for respiratory capacity, but go beyond that to affect the whole organelle morphology. This work explores the biophysical foundations of individual mitochondrial shape, suggesting potential links between mitochondrial structure and function. This should be of profound significance, particularly in the context of disrupted cristae shaping proteins and their implications in mitochondrial diseases.
It is widely acknowledged that biodiversity change is affecting human well-being by altering the supply of Nature's Contributions to People (NCP). Nevertheless, the role of individual species in this relationship remains obscure. In this article, we present a framework that combines the cascade model from ecosystem services research with network theory from community ecology. This allows us to quantitatively link NCP demanded by people to the networks of interacting species that underpin them. We show that this “network cascade” framework can reveal the number, identity and importance of the individual species that drive NCP and of the environmental conditions that support them. This information is highly valuable in demonstrating the importance of biodiversity in supporting human well-being and can help inform the management of biodiversity in social-ecological systems.
Tree-related microhabitats (TReMs) have been proposed as important indicators of biodiversity to guide forest management. However, their application has been limited mostly to temperate ecosystems, and it is largely unknown how the diversity of TReMs varies along environmental gradients. In this study, we assessed the diversity of TReMs on 180 individual trees and 44 plots alongside a large environmental gradient on Kilimanjaro, Tanzania. We used a typology adjusted to tropical ecosystems and a tree-climbing protocol to obtain quantitative information on TreMs on large trees and dense canopies. We computed the diversity of TReMs for each individual tree and plot and tested how TReM diversity was associated with properties of individual trees and environmental conditions in terms of climate and human impact. We further used non-metric multidimensional scaling (NMDS) to investigate the composition of TReM assemblages alongside the environmental gradients. We found that diameter at breast height (DBH) and height of the first branch were the most important determinants of TReM diversity on individual trees, with higher DBH and lower first branch height promoting TReM diversity. At the plot level, we found that TReM diversity increased with mean annual temperature and decreased with human impact. The composition of TReMs showed high turnover across ecosystem types, with a stark difference between forest and non-forest ecosystems. Climate and the intensity of human impact were associated with TReM composition. Our study is a first test of how TReM diversity and composition vary along environmental gradients in tropical ecosystems. The importance of tree size and architecture in fostering microhabitat diversity underlines the importance of large veteran trees in tropical ecosystems. Because diversity and composition of TReMs are sensitive to climate and land-use effects, our study suggests that TReMs can be used to efficiently monitor consequences of global change for tropical biodiversity.
Tree-related microhabitats (TReMs) have been proposed as important indicators of biodiversity to guide forest management. However, their application has been limited mostly to temperate ecosystems, and it is largely unknown how the diversity of TReMs varies along environmental gradients. In this study, we assessed the diversity of TReMs on 180 individual trees and 46 plots alongside a large environmental gradient on Kilimanjaro, Tanzania. We used a typology adjusted to tropical ecosystems and a tree-climbing protocol to obtain quantitative information on TreMs on large trees and dense canopies. We computed the diversity of TReMs for each individual tree and plot and tested how TReM diversity was associated with properties of individual trees and environmental conditions in terms of climate and human impact. We further used non-metric multidimensional scaling (NMDS) to investigate the composition of TReM assemblages alongside the environmental gradients. We found that diameter at breast height (DBH) and height of the first branch were the most important determinants of TReM diversity on individual trees, with higher DBH and lower first branch height promoting TReM diversity. At the plot level, we found that TReM diversity increased with mean annual temperature and decreased with human impact. The composition of TReMs showed high turnover across ecosystem types, with a stark difference between forest and non-forest ecosystems. Climate and the intensity of human impact were associated with TReM composition. Our study is a first test of how TReM diversity and composition vary along environmental gradients in tropical ecosystems. The importance of tree size and architecture in fostering microhabitat diversity underlines the importance of large veteran trees in tropical ecosystems. Because diversity and composition of TReMs are sensitive to climate and land-use effects, our study suggests that TReMs can be used to efficiently monitor consequences of global change for tropical biodiversity.
This thesis investigates the structure of the translocase of the outer membrane (TOM) complex in mitochondria, focusing on the TOM holo complex through single-particle electron cryo-microscopy (cryoEM) complemented by mass spectrometry and computational structure prediction. Mitochondria, crucial for energy production in eukaryotic cells, import most of their proteins from the cytoplasm. These proteins enter through the TOM complex, which in its core form consists of a membrane-embedded homodimer of Tom40 pores, two Tom22 cytoplasmic receptors, and six small TOM stabilizing subunits (Tom7, Tom6, and Tom5). The holo complex includes two additional subunits, Tom70 and Tom20, whose stoichiometry and positioning are less understood due to their easy dissociation during isolation of the complex. CryoEM analysis revealed the high-resolution structure of the Neurospora crassa TOM core complex at 3.3 Å, containing all core subunits, and the presence of a central phospholipid causing the Tom40 dimer to tilt to 20°. Furthermore, a 4 Å resolution map indicated the binding of a precursor protein as it transitions through the translocation barrel. Finally, at 6-7 Å resolution, the structure of the TOM holo complex highlighted Tom20's flexibility as it interacts with the core complex, emphasizing its role in protein translocation. This work provides significant insights into the architecture and functioning of the TOM complex, contributing to the understanding of mitochondrial protein import mechanisms.
This work focused on the biosynthesis and characterization of esterified lipid mediators. Lipid mediators were generally thought to exert their effects as free molecules, and their esterification was regarded as a storage mechanism. However, more recent studies indicate that esterified lipid mediators are a distinct class of mediators. When this thesis started back in 2017, the idea of esterified lipids as a new class of mediators was relatively new so that respective compounds were either quite expensive or not commercially available at all. Therefore, a biosynthetic approach had to be established first to enable the study of the new lipid mediator class. Within the cell, esterified lipids are produced by activation and subsequent incorporation of polyunsaturated fatty acids. These steps are enzymatically catalyzed by members of the acyl-CoA synthetase family and the lysophosphatidylcholine acyltransferase family, respectively. Therefore, the enzymes acyl-CoA synthetase long-chain family member 4 (ACSL4) and lysophosphatidylcholine acyltransferase 2 (LPCAT2) were selected for a biosynthetic approach due to their broad substrate acceptance.
In a first attempt, recombinant protein expression in E. coli was studied. While the expression and purification of C-terminally His6x-tagged ACSL4 resulted in a pure and active protein, the expression of LPCAT2 turned out quite troublesome. Although several expression and purification parameters were varied, including purification tags, buffer compositions, and chromatography strategies, successful purification of LPCAT2 was not achieved.
Instead, a second approach was studied. This time, stably transfected cells overexpressing ACSL4 and/or LPCAT2 were generated from the human embryonal kidney (HEK) 293T cell line. Stably transfected cell lines were characterized on protein level and regarding their oxylipin profile. After confirming the overexpression and functionality of the enzymes, lipoxygenases (LOs) were co-expressed in a doxycycline-inducible manner to prevent premature cell death due to increased oxidative stress. As a result, LO product formation was enhanced and enabled the investigation of specific oxylipins. Since increased lipid peroxidation is also a key component of the ferroptosis cell death mechanisms, cell lines were investigated towards their cell viability. Indeed, expression of ACSL4 and/or LPCAT2 promoted cell death when treated with the ferroptosis inducers erastin or RSL3, even in the absence of LO expression. Furthermore, analysis by laser scanning confocal microscopy revealed that the localization of 15-LO1 was altered in the presence of LPCAT2, similar to treatment with RSL3 in vector control cells.
In conclusion, a stable overexpression system of ACSL4 and/or LPCAT2 was successfully established in HEK293T cells, which enabled the synthesis and characterization of esterified oxylipins. Interestingly, characterization of the cell lines revealed a correlation with the cell death mechanism ferroptosis. Although the expression of ACSL4 has already been reported as a biomarker for ferroptosis, this is the first time that a potential connection of LPCAT2 with ferroptosis was demonstrated. As a result, this may provide new therapeutic options for ferroptosis-related pathologies such as neurodegeneration, autoimmune diseases, or tumorigenesis.
The ligand-sensing transcription factor Nurr1 emerges as a promising therapeutic target for neurodegenerative pathologies but Nurr1 ligands for functional studies and therapeutic validation are lacking. Here pronounced Nurr1 modulation by statins for which clinically relevant neuroprotective effects are demonstrated, is reported. Several statins directly affect Nurr1 activity in cellular and cell-free settings with low micromolar to sub-micromolar potencies. Simvastatin as example exhibits anti-inflammatory effects in astrocytes, which are abrogated by Nurr1 knockdown. Differential gene expression analysis in native and Nurr1-silenced cells reveals strong proinflammatory effects of Nurr1 knockdown while simvastatin treatment induces several neuroprotective mechanisms via Nurr1 involving changes in inflammatory, metabolic and cell cycle gene expression. Further in vitro evaluation confirms reduced inflammatory response, improved glucose metabolism, and cell cycle inhibition of simvastatin-treated neuronal cells. These findings suggest Nurr1 involvement in the well-documented but mechanistically elusive neuroprotection by statins.